Mortality trends in a cohort of opiate addicts, Catalonia, Spain

International Journal of Epidemiology

Volumn 25, Issue 3, 1996, Pages 545-553

  Ortí, Rafael M ^a,b   Domingo Salvany, Antònia ^a   Muñoz, Alvaro ^c   Macfarlane, Dave ^a   Suelves, Josep M ^d   Antó, Josep M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Generalitat Valenciana   (Spain)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Generalitat de Catalunya ^*  (Spain)

Author keywords

AIDS; Mortality; Opiate dependence; Survival analysis

Indexed keywords

OPIATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; DRUG DEPENDENCE; EMERGENCY WARD; FEMALE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MODEL; MORTALITY; OPIATE ADDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK; SEX DIFFERENCE; SPAIN;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; OPIOID-RELATED DISORDERS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SPAIN;

EID: 0029901049     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/25.3.545     Document Type: Article

References (53)

1. CDC. Years of potential life lost before age 65 - United States, 1990 and 1991. MMWR 1993; 42: 251-53, JAMA 1993; 269: 2842.
2. CDC. Years of potential life lost before age 65 - United States, 1990 and 1991. MMWR 1993; 42: 251-53, JAMA 1993; 269: 2842.
3. De la Fuente L, Barrio G, Vicente J, Bravo M J, Santacreu J. The impact of drug-related deaths on mortality among young adults in Madrid. Am J Public Health 1995; 85: 102-05.
4. De la Fuente L, Barrio G, Vicente J, Bravo M J, Santacreu J. Mortalidad relacionada con el uso de drogas: primera causa de mortalidad entre las personas de 15-39 años en la cuidad de Madrid. Gar Sanit 1994; 8(S44): (abstract).
5. Sánchez-Carbonell J, Brigos B, Cami J. Evolución de una muestra de heroinómanos dos años después del inicio del tratamiento (Proyecto EMETYST). Med Clin 1989; 92: 135-39.
6. Muga R, Tor J, Ginesta C et al. Natural history of parenteral drug addicts treated in a general hospital. Br J Addict 1990; 85: 775-78.
7. Cherubin C H, McCusker J, Baden M, Kavaler F, Amsel Z. The epidemiology of death in narcotic addicts. Am J Epidemiol 1972; 96: 11-22.
8. Watterson O, Simpson D D, Sells S B. Death rates and causes of death among opiate addicts in community drug treatment programs, 1970-1973. Am J Drug Alcohol Abuse 1975; 2: 99-111.
9. Joe G W, Lehman W, Simpson D D. Addict death rates during a four-year posttreatment follow-up. Am J Public Health 1982; 72: 703-09.
10. Wille R. Ten-year follow-up of a representative sample of London heroin addicts: Clinic attendance, abstinence and mortality. Br J Addict 1981; 76: 259-66.
11. Joe G W, Simpson D D. Mortality among opioid addicts in a longitudinal study. Am J Public Health 1987; 77: 347-48.
12. Cothell D, Childs-Clarke A, Ghodse A H. British opiate addicts; An 11-year follow-up. Br J Psychiatry 1985; 146: 448-50.
13. Helpern M, Rho Y M. Deaths from narcotism in New York City. Int J Addict 1967; 2: 53-85.
14. Selwyn P A, Hartel D, Wasserman W, Drucker E. Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health 1989; 79: 1358-62.
15. Oppenheimer E, Tobutt C, Taylor C, Andrew T. Death and survival in a cohort of heroin addicts from London clinics: A 22-year follow-up study. Addiction 1994; 89: 1299-308.
16. Eskild A, Magnus P M, Samuelson S O et al. Differences in mortality rates and causes of death between HIV positive and HIV negative intravenous drug users. Int J Epidemiol 1993; 22: 315-19.
17. Perucci C A, Davoli M, Rapiti E, Abeni D D, Forastiere F. Mortality of intravenous drug users in Rome: A cohort study. Am J Public Health 1991; 81: 1307-10.
18. Titti F, Lazzarin A, Costigliola P et al. Human immuno-deficiency virus seropositivity in intravenous drug abusers in three cities of Italy: Possible natural history of HIV infection in i.v. drug addicts in Italy. J Med Virol 1987; 23: 241-48.
19. Lardelli P, De la fuente L, Alonso J M, López R, Bravo M J, Delgado-Rodriguez M. Geographical variations in the prevalence of HIV infection among drug users receiving ambulatory treatment in Spain. Int J Epidemiol 1993; 22: 306-14.
20. Centro Nacional de Epidemiología. Registro Nacional del SIDA. Informe trimestral No. 4, 1994. Madrid: Instituto de Salud Carlos III, 1995.
21. Sanchez J, Rodriguez B, De la Fuente L et al. Opiates or cocaine: mortality from acute reactions in six major Spanish cities. J Epidemiol Community Health 1995; 49: 54-60.
22. Domingo A, Anto J M, Camí J. Epidemiological surveillance of opioid-related episodes in an emergency room of Barcelona, Spain (1979-1989). Br J Addict 1991; 86: 1459-66.
23. Domingo-Salvany A, Hartnoll R L, Anto J M. Opiate and cocaine consumers attending Barcelona emergency rooms: A one-year survey (1989). Addiction 1993; 88: 1247-56.
24. Grupo de Trabajo del SEIT. Admisiones a tratamiento por consumo de opiáceos o cocaína en España. Gac Sanit 1990; 4: 4-11.
25. Sánchez-Carbonell J, Camí J, Brigos B. Follow-up of heroin addicts in Spain (EMETYST Project): Results 1 year after treatment admission. Br J Addict 1988; 83: 1439-48.
26. Newcombe H B. Handbook of Record Linkage. Methods for Health and Statistical Studies, Administration, and Business. Oxford: Oxford University Press, 1988.
27. Ortí R M, Macfarlane D, Domingo-Salvany A. Obtención de una cohorte de adictos a opiáceos a partir de la conexión de registros confidenciales. Gac Sanit 1994; 8: 229-38.
28. European Centre for AIDS Surveillance. 1993 Revision of the European AIDS Surveillance Case Definition, Paris. Report 37/1993, pp. 23-38.
29. Muñoz A, Hoover D R. Use of cohort studies for evaluating AIDS therapies. In: Fintelstein D M, Salverbaum D A (eds). AIDS Clinical Trials. New York: JohnWiley, 1995.
30. EGRET. Statistics Package. Seattle, WA: Statistic and Epidemiological Research Corporation and Cytel Software Corp., 1991.
31. Breslow N E, Day N E. Statistical Methods in Cancer Research. Vol. I. The Analysis of Case-Control Studies. Lyon: IARC Scientific Publications No. 32, 1980.
32. Miller R, Gong G, Muñoz A. Survival Analysis. New York: John Wiley, 1981.
33. Stoneburner R L, Des Jarlais D C, Benezra L G et al. A larger spectrum of severe HIV-1 related disease in intravenous drug users in New York City. Science 1988; 242: 916-19.
34. Perucci C A, Forastiere F, Rapiti E, Davoli M, Abei D D. The impact of intravenous drug use on mortality of young adults in Rome, Italy. Br J Addict 1992; 87: 1637-41.
35. Hahn R A, Onorato I M, Jones T S, Dougherty J. Prevalence of HIV infection among IVDU in the USA. JAMA 1989; 261: 2677-84.
36. Des Jarlais D C, Friedman S R, Novick D M et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA 1989; 261: 1008-12.
37. Mandelli C, Conte D, Barbera R et al. Prevalence of HIV infection in 646 heroin addicts and outcome of HIV-related conditions in the 266 followed up. Eur J Epidemiol 1991; 7: 83-87.
38. Caylà J A, Jansà J M, Iglesias B, Artazcoz L, Plasència A. Epidemiología del síndrome de immunodeficiencia adquirida en Barcelona (1981-1991) (I) Estudio descriptivo y en tendencias temporales. Med Clin (Barc) 1993; 101: 286-93.
39. Samkoff J S, Baker S P. Recent trends in fatal poisoning by opiates in the United States. Am J Public Health 1982; 72: 1251-56.
40. Tunving K. Fatal outcome in drug addiction. Acta Psychiatr Scand 1988; 77: 551-66.
41. Engström A, Adamson C, Allebeck P, Rydberg U. Mortality in patients with substance abuse: A follow-up in Stockholm County, 1973-1984. Br J Addict 1991 26: 91-106.
42. Rezza G, Dorrucci M, Filibeck U, Serafin I. Estimating the trend of the epidemic of drug use in Italy, 1985-89. Br J Addict 1992; 87: 1643-48.
43. Haberman P W, French J F, Chin J. HIV infection and IV drug use: Medical examiner cases in Essex and Hudson counties, New Jersey. Am J Drug Alcohol Abuse 1993; 19: 299-307.
44. Zunzunegui Pastor M V, Rodriguez Arenas M A, Sarasqueta Eizaguirre C. Drogaddición intravenosa y riesgo de infección por VIH en Madrid 1990. Gac Sanit 1993; 7: 2-11.
45. James P. Suicide and mortality amongst heroin addicts in Britain. Br J Addict 1967; 62: 391-98.
46. Frischer M, Bloor M, Goldberg D, Clark J, Green S, McKeganey N. Mortality among injecting drug users: A critical reappraisal. J Epidemiol Community Health 1993; 47: 59-63.
47. Sistema Estatal de Información sobre Toxicomanías (SEIT). Informe Año 1992. Madrid: Plan Nacional sobre Drogas, 1993.
48. San L, Lopes Colomés J L, Ollé J M, Tremoleda J. Patología orgánica en adictos a heroína por vía parenteral: 1982-1988. In: Libro de resúmenes de II Congreso de la Sociedad Española de Toxicomanías. Vitoria: SET, 1989 (abstract).
49. Davoli M, Perucci C A, Forastiere F et al. Risk factors for overdose mortality: A case-control study within a cohort of intravenous drug users. Int J Epidemiol. 1993; 22: 273-77.
50. Grönbladh L, Öhlund L S, Gunne L M. Mortality in heroin addiction: Impact of methadone treatment. Acta Psychiatr Scand 1990; 82: 223-27.
51. Domingo-Salvany A, Hartnoll R L, Maguire A, Suelves J M, Antó J M. Use of capture-recapture to estimate the prevalence of opiate addiction in Barcelona, Spain, 1989. Am J Epidemiol 1995, 141: 567-74.
52. Pollock D A, Holmgreen P, Kung-Jong L, Kirk M L. Discrepancies in the reported frequency of cocaine-related deaths, United States, 1983 through 1988. JAMA 1991; 266: 2233-37.
53. Buehler J W, Devine O J, Berkelman R L, Chevarley F M. Impact of the human immunodeficiency virus epidemic on mortality trends in young men, Unites States. Am J Public Health 1990; 80: 1080-86.